BioVie Inc. Increase (Decrease) in Prepaid Expense
BioVie Inc. (BIVI) reported Increase (Decrease) in Prepaid Expense of $6.98 thousand for the 12-month period ending 2017-06-30, per its 10-K filed 2018-10-05.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2018-10-05
- BioVie Inc. increase (decrease) in prepaid expense for the quarter ending 2017-06-30 was $0.00.
- BioVie Inc. increase (decrease) in prepaid expense for the quarter ending 2017-03-31 was $0.00, a 100.00% decline year-over-year.
- BioVie Inc. increase (decrease) in prepaid expense for the quarter ending 2016-12-31 was $0.00.
- BioVie Inc. increase (decrease) in prepaid expense for the quarter ending 2016-09-30 was $6.98K, a 365.47% increase year-over-year.
- BioVie Inc. increase (decrease) in prepaid expense for fiscal 2017 was $6.98K.
- BioVie Inc. increase (decrease) in prepaid expense for fiscal 2016 was -$4.98K.
- BioVie Inc. increase (decrease) in prepaid expense for fiscal 2015 was -$2.00K.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 6 month as first filed | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 12 month |
|---|---|---|---|---|---|
| 2017-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-05 | $0.00 derived: sum of 2 quarters · filed 2018-10-05 | $0.00 derived: sum of 3 quarters · filed 2018-10-05 | $6.98K 10-K · filed 2018-10-05 | |
| 2017-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-14 | $0.00 derived: sum of 2 quarters · filed 2018-05-14 | $6.98K 10-Q · filed 2018-05-14 | $0.00 derived: sum of 4 quarters · filed 2018-05-14 | |
| 2016-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-14 | $6.98K 10-Q · filed 2018-02-14 | $0.00 derived: sum of 3 quarters · filed 2018-02-14 | $4.00K derived: sum of 4 quarters · filed 2018-02-14 | |
| 2016-09-30 | $6.98K 10-Q · filed 2017-11-08 | $0.00 derived: sum of 2 quarters · filed 2017-11-08 | $4.00K derived: sum of 3 quarters · filed 2017-11-08 | $500.00 derived: sum of 4 quarters · filed 2017-11-08 | |
| 2016-06-30 | -$6.98K derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-24 | -$2.98K derived: sum of 2 quarters · filed 2017-08-24 | -$6.48K derived: sum of 3 quarters · filed 2017-08-24 | -$4.98K 10-K · filed 2017-08-24 | |
| 2016-03-31 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-09 | $500.00 derived: sum of 2 quarters · filed 2017-05-09 | $2.00K 10-Q · filed 2017-05-09 | $3.50K derived: sum of 4 quarters · filed 2017-05-09 | |
| 2015-12-31 | -$3.50K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2017-02-07 | -$2.00K 10-Q · filed 2017-02-07 | $2.00K 10-Q · filed 2016-02-16 | -$500.00 derived: sum of 3 quarters · filed 2017-02-07 | $1.00K derived: sum of 4 quarters · filed 2017-02-07 |
| 2015-09-30 | $1.50K 10-Q/A · filed 2017-01-19 | $3.00K derived: sum of 2 quarters · filed 2017-01-19 | $4.50K derived: sum of 3 quarters · filed 2017-01-19 | ||
| 2015-06-30 | $1.50K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-28 | $3.00K derived: sum of 2 quarters · filed 2016-09-28 | -$2.00K 10-K · filed 2016-09-28 | ||
| 2015-03-31 | $1.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-23 | -$3.50K 10-Q · filed 2016-05-23 | |||
| 2014-12-31 | -$5.00K 10-Q · filed 2016-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |